Jeena Sikho Lifecare Q4FY26: Strong YoY Growth, Sequential Moderation

Key Highlights • Revenue: ₹215.55 Cr (↑54.80% YoY, ↓2.76% QoQ) • EBITDA: ₹77.92 Cr (↑70.24% YoY, ↓22.64% QoQ) • EBITDA Margin: 36.15% vs 32.87% YoY, 45.44% QoQ • PAT: ₹45.08 Cr (↑77.89% YoY, ↓32.31% QoQ) Profitability • PBT (Ex-Exceptional): ₹61.23 Cr (↑80.53% YoY, ↓31.15% QoQ) • PAT After Minority Interest: ₹45.13 Cr (↑78.11% YoY, ↓32.30% QoQ) • Other Income: ₹3.42 Cr vs ₹0.27 Cr YoY What Stands Out • Strong growth across revenue and profitability on a yearly basis • EBITDA margins improved significantly YoY • Sequential decline in profits and margins after a strong previous quarter Why It Matters The company continues to deliver robust growth, though quarterly normalization in margins and earnings warrants monitoring. Learning Outcome When evaluating fast-growing healthcare businesses, investors should assess both growth rates and margin sustainability rather than focusing on a single quarter. $JSLL